356 related articles for article (PubMed ID: 12054679)
1. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
3. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
4. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
Zhou CH; Wu XH; Wu YQ
Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
7. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase.
Liu D; Gao L; Roy SK; Cornish KG; Zucker IH
Circ Res; 2006 Oct; 99(9):1004-11. PubMed ID: 17008603
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
[TBL] [Abstract][Full Text] [Related]
10. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.
Kyaw M; Yoshizumi M; Tsuchiya K; Izawa Y; Kanematsu Y; Tamaki T
Acta Pharmacol Sin; 2004 Aug; 25(8):977-85. PubMed ID: 15301727
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in MAP kinase activity in VSMC in response to glucose or TNF-alpha.
Li M; Mossman BT; Kolpa E; Timblin CR; Shukla A; Taatjes DJ; Fukagawa NK
J Cell Physiol; 2003 Dec; 197(3):418-25. PubMed ID: 14566971
[TBL] [Abstract][Full Text] [Related]
13. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
Won SM; Park YH; Kim HJ; Park KM; Lee WJ
Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
15. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts.
Li JM; Cui TX; Shiuchi T; Liu HW; Min LJ; Okumura M; Jinno T; Wu L; Iwai M; Horiuchi M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):80-4. PubMed ID: 14592853
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla.
Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY
Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
20. Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells.
Ishizawa K; Izawa-Ishizawa Y; Ohnishi S; Motobayashi Y; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Minakuchi K; Tamaki T
J Pharmacol Sci; 2009 Feb; 109(2):257-64. PubMed ID: 19202317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
